Back
Kymera Therapeutics Stock Predictions
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
67
KYMR
Kymera Therapeutics
Last Price:
49.80
Seasonality Move:
25.63%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Kymera Therapeutics Stock Forecast
- Over the next 52 weeks, Kymera Therapeutics has on average historically risen by 52% based on the past 4 years of stock performance.
- Kymera Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Kymera Therapeutics Stock Undervalued?
The current Kymera Therapeutics [KYMR] share price is $49.79. The Score for KYMR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal. - KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Kymera Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Kymera Therapeutics has on average historically risen by 52% based on the past 4 years of stock performance.
Kymera Therapeutics Stock Rating
Buy
67
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics overpriced?
- Kymera Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Kymera Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kymeratx.com
52-Week Data
52-Week High:
50.69
52-Week Low:
9.60
Prediction Charts
Market Cap:
3.07B
Price in USD:
49.79
Volume:
1.23M
Beta:
2.20
Technical Analysis
SMA50:
45.16
SMA100:
39.61
SMA200:
36.65
52-Wk Change:
185.99%
Stock Predictions
-
Is Kymera Therapeutics stock public?
Yes, Kymera Therapeutics is a publicly traded company. -
What is the Kymera Therapeutics stock quote today?
The Kymera Therapeutics stock price is 49.79 USD today. -
How to buy Kymera Therapeutics stock online?
You can buy Kymera Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Sep-3 | 47.70 | 46.27 | 48.84 | 46.26 |
| Sep-4 | 45.92 | 46.17 | 47.10 | 45.39 |
| Sep-5 | 46.29 | 46.60 | 46.69 | 45.34 |
| Sep-6 | 47.04 | 45.40 | 48.53 | 43.90 |
| Sep-9 | 46.06 | 46.19 | 47.02 | 45.66 |
| Sep-10 | 46.56 | 46.88 | 46.93 | 44.95 |
| Sep-11 | 46.49 | 44.77 | 46.90 | 44.65 |
| Sep-12 | 44.70 | 44.72 | 46.03 | 44.20 |
| Sep-13 | 45.07 | 46.08 | 46.47 | 44.53 |
| Sep-16 | 46.42 | 48.48 | 49.15 | 46.00 |
| Sep-17 | 48.73 | 47.30 | 49.20 | 47.25 |
| Sep-18 | 47.51 | 46.45 | 48.33 | 45.67 |
| Sep-19 | 48.34 | 49.03 | 50.69 | 47.57 |
| Sep-20 | 49.04 | 49.79 | 50.25 | 48.05 |
Kymera Therapeutics Earnings
Kymera Therapeutics Earnings Report: Per Share Kymera Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Kymera Therapeutics Forecast Revenue Growth
Kymera Therapeutics Stock Analysis: Historical quarterly revenues per share for Kymera Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.22 per share, and a decrease next year of $0.53 per share.
* Kymera Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.